{"name":"Gemin X","slug":"gemin-x","ticker":"","exchange":"","domain":"","description":"Gemin X is a biotechnology company focused on the development of novel therapies for cancer. The company has a pipeline of four drug candidates, with a focus on advancing treatments through early-stage clinical trials. Despite facing setbacks, Gemin X continues to explore innovative approaches in oncology.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMitAJBVV95cUxOUEFfUDJZcHplbWNUZkxSenJHQjR1Y1NmbjVWcEQ1RlRRTkR4LUZpamstSDB6cXp4R2xyWXYzTW13enV3bXdoaDg5bHRkSHlueW5wbEZfSVRaSEZQeWVma25OMkdOTDVNeDhQQ0ZuVWhSbXdtbk8yd2ZXZ0V0eENVUTByMmkySDJNWWY0QWdMNXJwRnRhcmRaSEF0Zm5IUHA2S2tYcm9ZN1RQcGppbjBJUVZEN3ZUV1ozZWhuMWJTZkxnV0V3WEszcFE2ZTlEUk5DRjRBSkFlQ1RncGxPSGY1SGRYYWZKblI5NEJINWIyZWlkMTI2el9HNTFzYmJkTVN2ejRNSmIwQzZxbGpKbnh0aGVZTkc2amI4a1lqNm5hV3NuM0tRc3lqemQ3dm5MdnRidlk3Qw?oc=5","date":"2026-02-25","type":"regulatory","source":"PR Newswire","summary":"Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment of Generalized Pustular Psoriasis - PR Newswire","headline":"Vanda Pharmaceuticals Announces FDA Acceptance of Biologics License Application Filing for Imsidolimab for the Treatment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxQVGFUSEpxTE0wSjE1TWZlcVNaclVaWFB0bXpQYVZpeFZLdEpwYUpBVEk4NVRoRkpFYU50cm15enpLZU56NXR6QklNdE5mUkVtZ203UHQxRmtWOXlHRzNOdF9ZSGRiVENIQ0hoblE3RUhaNkVnT0pPd0tTV2U4enNtdUpYRXVYRWtOcjNQUUdHS3Q3M0NHS19Yem5ONkVGVndPMWI3am1vSlZHUmJzamJ0NWFpRDQ3UTFGRUJ5b0tSeDlKb0l3VXZBTUtyVXhnV0xaQVRQN0xMYkJqNEJiaTJpVWVwem9SakhLSnYwaXN5WlJUT0o4VEZTZjJSOHlfQzU3bmluMEVZZ1lfUWE0Z015OXJrZlV1Y3ZaQjlrWEw1VmVQVGZ2M2c2a01JMnQ4Mlpxcl91UEdWUl8xdUk?oc=5","date":"2025-11-04","type":"trial","source":"GlobeNewswire","summary":"Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP Receptor Agonist HRS9531 - GlobeNewswire","headline":"Hengrui Pharma and Kailera Therapeutics Announce Additional Data from Phase 3 Obesity Trial in China of Dual GLP-1/GIP R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQWTNJQm1RQTRYYXo5SGJ6TGRiOTFMU1VlaWxiaHkxUmZVM2ZkajhfWkZ0S0JVRDQtcDB5a3IxRjdVNmU4Q1htd1ByQWNSYVc2akw0SGlqTk9RaGlwb0JYby04VFhUMFZIN1BfSzhEVTQ0YTB4S1hxNjJpZ25lbTh5YUZjODdwMUM4TDNmdzZkekNOaEpmSC00?oc=5","date":"2025-09-02","type":"pipeline","source":"Newsday","summary":"Long Island firms win tax breaks for $25M growth - Newsday","headline":"Long Island firms win tax breaks for $25M growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTE9oN3Q1azlmN0ctLUcwbXFYaFVRME1CQm9lQkV1b2NfUGdmVURndHpjWVdUd1FfcDdRZXBxb0UwVFQxY1p1VGQtTUlSVWw2LTdtWTluRVk5d2hheGE1TXNXRVhaTTFQeDl1Q1Z5OWo3dHpzYURD?oc=5","date":"2024-05-15","type":"pipeline","source":"research.google","summary":"Advancing medical AI with Med-Gemini - research.google","headline":"Advancing medical AI with Med-Gemini","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQNGVEc2tTQldXdnBIZUE5R1NSSVI3Rm5ORHJQTkdpaG4xaFVZRHZxRVFnaFo2cGZ0eHhKZ0VTUTlEOXdBQ055cGJhS1FyaVhZeVpQRTd4VkNfRW5aRnFfc1Zkc0lWOFM2WlpnU1M2QjdYWkloZkREcnFnVi1ZTV9ldi1kLXZVWjJaazZaMVJn?oc=5","date":"2022-08-10","type":"pipeline","source":"BioPharma Dive","summary":"Gemini’s fall gives Disc a way around biotech’s IPO slump - BioPharma Dive","headline":"Gemini’s fall gives Disc a way around biotech’s IPO slump","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBXSFhwRDZnSTZHRnluSnUzYzREdEkxZEEwWlVUZ3daZzF3YXdRREhGUEh1U0t5UllTaXRVcE04bmFhUXV1a2h4cGk2cjlYeFFaLTlvVnp5Y1p1U3BDVWVUR2tmTVltUXk1YXJwNDJLNVE5MFE2?oc=5","date":"2020-03-24","type":"deal","source":"Pharmaceutical Technology","summary":"Bayer inks drug development and licensing deal with India’s Curadev - Pharmaceutical Technology","headline":"Bayer inks drug development and licensing deal with India’s Curadev","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTE10WG84WGY0WXl2VFJqaF9obXhhaWt4V2RtYldvamc1U3NHOTc1MGtnYjdXU05RT3M4U1ZJcGlTbW90Z0FKYmhwSlhBNGxMOG9Nbml0SWxuUi1TQ2ozOU1XMXlwS3JPQmEzUllnTmlmb0RxeC03LUxiYUxpMA?oc=5","date":"2019-10-15","type":"pipeline","source":"Pharmaceutical Technology","summary":"Takeda to sell primary care portfolio in emerging markets to Acino - Pharmaceutical Technology","headline":"Takeda to sell primary care portfolio in emerging markets to Acino","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPSjZQMTVYXzNLZ1lhR2ZzMWFfMWhQaW9CSUdjeG03SmwzTm9LSEZqZGdzNDlkaEpQTThoamx6OUpKZjIzOGE4amp2amVRb1B4TloyVVRFSWVpcGxibDdsS19GU1pzNkRvOW1UamNuMTlYN1NIbGxtR1VpTFl1c2JRQ3MxbzNPd0htZ0MyRDVYeDloXzdSVUtaZzBnYVJPdEE?oc=5","date":"2019-10-02","type":"deal","source":"Contract Pharma","summary":"Gemini Bio-Products Forms Partnership with FroggaBio - Contract Pharma","headline":"Gemini Bio-Products Forms Partnership with FroggaBio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxNUm1KYkw1SjVzMWhzTUJJT2I5ODRuV1ZrYkc1TmIxZGN5bnNwQXcyVUt2UUtyZEFrUGpNaHBwR1BwYlVVNlVxTnhFNlpYcWRDemlOZmhpSjZfU21mS21OdmdHU2ZETFZyQlRvXzJtV1FPcFZUdVRzUXluNk1ENzBwT2lqZzF3b2hGQXp2aTAzTndHVTZiZUxOVk4tSklCWm8tRW81NGhsdE0tYlZpbWp5YzlEa0MtNXZyVWp5QmNjVHdPeF83azlMdVVINV8yRGFnYjJvUg?oc=5","date":"2019-09-19","type":"earnings","source":"Pharmaceutical Technology","summary":"Pfizer Mylan merger: may see revenues reach $20bn by 2020 - Pharmaceutical Technology","headline":"Pfizer Mylan merger: may see revenues reach $20bn by 2020","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNazBuanZwVUlIOXoyOVJHV1l5QW0zek10ZDc3dVdlUEN2TlJrb0RoYWdneFR2d3d4REsxQXVySTc1c3Z0OUlzWjNuRkN4SkxMeHM0QnBGMzlFXzR4ZWtlR3NqU29FVkxKVi05MGRMbTYtam1NcGVnUmtiZ25pcWg0UW9oYy1yZw?oc=5","date":"2019-09-11","type":"deal","source":"Pharmaceutical Technology","summary":"GSK to buy Sitari Pharmaceuticals from Avalon Ventures - Pharmaceutical Technology","headline":"GSK to buy Sitari Pharmaceuticals from Avalon Ventures","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOczNiZlJiMWFielNzaXN4TEQ5MTNOV3RlYWhqZmtyeE5WZnoxUWt0akJ5UC02MmRoSDJYUHpkMEFWX1FlQXE1ZWpwMWw0ekZPbDh6N2NkM2d4MldXWmFuRmxjZFNuR3lkWlhIdEpNY2JBR3hPTUlhWWNMM0liWUJaUnFpYVVwTW04b2hN?oc=5","date":"2019-06-14","type":"pipeline","source":"Pharmaceutical Technology","summary":"Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets - Pharmaceutical Technology","headline":"Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPQnZCd2RDSGZlWmQ5NlNTeWZZN016UTNFRFp5NTFIdXRRcXltT1c4YklvaDBVeE1JWFRXTzgyZjlid2Jxdl9BNkdqN244RFhPUWg5VzJYbjNPcjBtaTFkVmYxUWoyNjlJY0dYTnNFcHpqU2hiaXZ0di1oWkJXTDJpcXQ3SU9QbXRlNnNCYUlrbUI2UlFLY3Y4V1lwSmlEQU9OUGc5Mw?oc=5","date":"2017-12-04","type":"deal","source":"Pharmaceutical Technology","summary":"Astellas acquires drug discovery subsidiary Mitobridge - Pharmaceutical Technology","headline":"Astellas acquires drug discovery subsidiary Mitobridge","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}